Lu, C., Kang, T., Zhang, J., Yang, K., Liu, Y., Song, K., Lin, Q., Dixit, D., Gimple, R. C., Zhang, Q., Shi, Z., Fan, X., Wu, Q., Li, D., Shan, D., Gao, J., Gu, D., You, H., Li, Y., … Wang, X. (2025). Combined targeting of glioblastoma stem cells of different cellular states disrupts malignant progression. Nature Communications, 16(1). https://doi.org/10.1038/s41467-025-58366-5

Maurer, K., Park, C. Y., Mani, S., Borji, M., Raths, F., Gouin, K. H., Penter, L., Jin, Y., Zhang, J. Y., Shin, C., Brenner, J. R., Southard, J., Krishna, S., Lu, W., Lyu, H., Abbondanza, D., Mangum, C., Olsen, L. R., Lawson, M. J., … Azizi, E. (2025). Coordinated immune networks in leukemia bone marrow microenvironments distinguish response to cellular therapy. Science Immunology, 10(103). https://doi.org/10.1126/sciimmunol.adr0782

Chatila, Z. K., Mares, J., Vardarajan, B. N., Elyaman, W., Menon, V., & Bradshaw, E. M. (2024). Microglial Activation Alters Chromatin Accessibility of AD‐Associated Transcription Factors. Alzheimer’s & Dementia, 20(S1). Portico. https://doi.org/10.1002/alz.085990

Green, J. L., Dressman, D., Rashid, M., Hobson, R., Elyaman, W., & Bradshaw, E. M. (2024). CD33 competitive inhibitor peptide IMAD‐001 modulates innate immunity in Alzheimer’s disease. Alzheimer’s & Dementia, 20(S6). Portico. https://doi.org/10.1002/alz.089331

Sikdar, S., Mitra, D., Das, O., Bhaumik, M., & Dutta, S. (2024). The functional antagonist of sphingosine-1-phosphate, FTY720, impairs gut barrier function. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1407228

Wu, X., Wang, Z., Shern, T., & Zhang, H. (2024). Efferocytosis assay to quantify the engulfment and acidification of apoptotic cells by macrophages using flow cytometry. STAR Protocols, 5(3), 103215. https://doi.org/10.1016/j.xpro.2024.103215

Nguyen, T. T. T., Gao, Q., Mun, J.-Y., Zhu, Z., Shu, C., Naim, A., Rogava, M., Izar, B., Westhoff, M.-A., Karpel-Massler, G., & Siegelin, M. D. (2024). Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma. Cells, 13(13), 1155. https://doi.org/10.3390/cells13131155

Haq, I., Ngo, J. C., Roy, N., Pan, R. L., Nawsheen, N., Chiu, R., Zhang, Y., Fujita, M., Soni, R. K., Wu, X., Bennett, D. A., Menon, V., Olah, M., & Sher, F. (2024). An integrated toolkit for human microglia functional genomics. Stem Cell Research & Therapy, 15(1). https://doi.org/10.1186/s13287-024-03700-9

He, S., Jin, Y., Nazaret, A., Shi, L., Chen, X., Rampersaud, S., Dhillon, B. S., Valdez, I., Friend, L. E., Fan, J. L., Park, C. Y., Mintz, R. L., Lao, Y.-H., Carrera, D., Fang, K. W., Mehdi, K., Rohde, M., McFaline-Figueroa, J. L., Blei, D., … Azizi, E. (2024). Starfysh integrates spatial transcriptomic and histologic data to reveal heterogeneous tumor–immune hubs. Nature Biotechnology. https://doi.org/10.1038/s41587-024-02173-8

Qian, J., Ryeom, S., Daugherty, B. L., Lederman, S., & Wang, T. C. (2023). 481 A CXCR4 partial agonist TFF2-MSA sensitized advanced gastric cancer to PD-1 blockade by systematically reducing PMN-MDSC accumulation, immunosuppression, and generation in bone marrow. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2023-sitc2023.0481

Daugherty, B. L., Boohaker, R. J., Johnstone, R., Stinson, K., Zhao, G., Zang, M., Qian, J., Wang, T. C., & Lederman, S. (2023). 1345 mTFF2-MSA (mTNX-1700) suppresses tumor growth and increases survival in anti-PD-1 treated CT26.wt subcutaneous and CT26-Luciferase orthotopic syngeneic colorectal cancer models by targeting MDSCs. Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2023-sitc2023.1345

Patel, S. P., Carvajal, R., Montazeri, K., Reddy, S., Lutzky, J., Khan, S. A., Chmielowski, B., Bhatia, S., Medina, T., Haymaker, C., Sheth, R., Kuban, J. D., Thornton, L., Wehrenberg-Klee, E., Novelli, P., Lucci, A., Sarli, V., Meas, S., Cox, B., … Davar, D. (2023). 1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial. Late-Breaking Abstracts. https://doi.org/10.1136/jitc-2023-sitc2023.1534

Sanchini, C., Rosito, M., Comincini, A., De Panfilis, S., Bartolini, F., & Di Angelantonio, S. (2023). Protocol for observing microtubules and microtubule ends in both fixed and live primary microglia cells. STAR Protocols, 4(3), 102499. https://doi.org/10.1016/j.xpro.2023.102499

Chen, L., Shi, V., Wang, S., Sun, L., Freeman, R., Yang, J., Inkman, M. J., Ghosh, S., Ruiz, F., Jayachandran, K., Huang, Y., Luo, J., Zhang, J., Cosper, P., Luke, C. J., Spina, C. S., Grigsby, P. W., Schwarz, J. K., & Markovina, S. (2023). SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production. Journal of Clinical Investigation, 133(15). https://doi.org/10.1172/jci163841

Hobson, B. D., Stanley, A. T., De Los Santos, M. B., Culbertson, B., Mosharov, E. V., Sims, P. A., & Sulzer, D. (2023). Conserved and cell type-specific transcriptional responses to IFN-γ in the ventral midbrain. Brain, Behavior, and Immunity, 111, 277–291. https://doi.org/10.1016/j.bbi.2023.04.008

Laternser, S., Petrovic, A., Eze, A., Dettwiler, S., Prutek, F., Contini, P. A., Morinigo, D., Bornhorst, M., Rushing, E. J., McDonough, E., Surrette, C., Ginty, F., Minnis, H., Gartrell, R., Müller, S., Packer, R., & Nazarian, J. (2023). DIPG-25. MAPPING TUMOR MICROENVIRONMENT USING EMERGING TECHNOLOGIES FOR PEDIATRIC BRAIN CANCERS. Neuro-Oncology, 25(Supplement_1), i18–i18. https://doi.org/10.1093/neuonc/noad073.072

Shin, A. E., Tesfagiorgis, Y., Larsen, F., Derouet, M., Zeng, P. Y. F., Good, H. J., Zhang, L., Rubinstein, M. R., Han, Y. W., Kerfoot, S. M., Nichols, A. C., Hayakawa, Y., Howlett, C. J., Wang, T. C., & Asfaha, S. (2023). F4/80+Ly6Chigh Macrophages Lead to Cell Plasticity and Cancer Initiation in Colitis. Gastroenterology, 164(4), 593-609.e13. https://doi.org/10.1053/j.gastro.2023.01.002

Obradovic, A. (2023). Precision immunotherapy. Science, 379(6633), 654–655. https://doi.org/10.1126/science.adg5585

Mannes, P. Z., Barnes, C. E., Biermann, J., Latoche, J. D., Day, K. E., Zhu, Q., Tabary, M., Xiong, Z., Nedrow, J. R., Izar, B., Anderson, C. J., Villanueva, F. S., Lee, J. S., & Tavakoli, S. (2023). Molecular imaging of chemokine-like receptor 1 (CMKLR1) in experimental acute lung injury. Proceedings of the National Academy of Sciences, 120(3). https://doi.org/10.1073/pnas.2216458120

Schvartzman, J. M., & Intlekofer, A. M. (2022). D-2HG comes out of its shell: Metabolic effects on the immune environment. Molecular Cell, 82(23), 4407–4409. https://doi.org/10.1016/j.molcel.2022.11.005

Tanagala, K. K. K., Morin-Baxter, J., Carvajal, R., Cheema, M., Dubey, S., Nakagawa, H., Yoon, A., Cheng, Y.-S. L., Taylor, A., Nickerson, J., Mintz, A., & Momen-Heravi, F. (2022). SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response. Journal for ImmunoTherapy of Cancer, 10(12), e005088. https://doi.org/10.1136/jitc-2022-005088

Zhou, R. W., Xu, J., Martin, T. C., Zachem, A. L., He, J., Ozturk, S., Demircioglu, D., Bansal, A., Trotta, A. P., Giotti, B., Gryder, B., Shen, Y., Wu, X., Carcamo, S., Bosch, K., Hopkins, B., Tsankov, A., Steinhagen, R., Jones, D. R., … Parsons, R. E. (2022). A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-33377-8

Gupta, P., Dang, M., Hao, D., Bojja, K., Tran, T., Shehwana, H., Kamiya-Matsuoka, C., Li, J., Audia, A., Kassab, C., Ott, M., Gumin, J., Alenazy, S., Goldman, A., Seth, S., Maheshwari, A., Balasubramaniyan, V., Vaillant, B., Groot, J. de, … Bhat, K. (2022). 1001 Immunophenotyping of brain tumors identifies interferon enriched phagocytes in human gliomas. Regular and Young Investigator Award Abstracts, A1043–A1043. https://doi.org/10.1136/jitc-2022-sitc2022.1001

Peereboom, D., Lindsay, R., Badruddoja, M., Nabors, L. B., Kumthekar, P., Lieberman, F., Tran, D., Phuphanich, S., Schiff, D., Sherman, J., Butowski, N., Dunbar, E., Fink, K., Iwamoto, F., Moertel, C., Schulder, M., Walbert, T., Habboubi, N., Grzegorzewski, K., … Reardon, D. A. (2022). CTIM-29. PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GBM: IDENTIFICATION OF TREATMENT-INDUCED CD8+CD107A+ CD57+ PD-1- MEMORY T-CELLS THAT ARE ASSOCIATED WITH INCREASED SURVIVAL. Neuro-Oncology, 24(Supplement_7), vii67–vii67. https://doi.org/10.1093/neuonc/noac209.261

Alvarez-Breckenridge, C., Markson, S. C., Stocking, J. H., Nayyar, N., Lastrapes, M., Strickland, M. R., Kim, A. E., de Sauvage, M., Dahal, A., Larson, J. M., Mora, J. L., Navia, A. W., Klein, R. H., Kuter, B. M., Gill, C. M., Bertalan, M., Shaw, B., Kaplan, A., Subramanian, M., … Carter, S. L. (2022). Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition. Cancer Immunology Research, 10(8), 996–1012. https://doi.org/10.1158/2326-6066.cir-21-0870

Yang, M., Fan, Q., Hei, T. K., Chen, G., Cao, W., Meng, G., & Han, W. (2022). Single-Cell Transcriptome Analysis of Radiation Pneumonitis Mice. Antioxidants, 11(8), 1457. https://doi.org/10.3390/antiox11081457

Schilperoort, M., Ngai, D., & Tabas, I. (2022). Efferocytosis induces a transient burst of glycolysis in macrophages to promote lactate-driven binding and continuing removal of apoptotic cells. Atherosclerosis, 355, 1–2. https://doi.org/10.1016/j.atherosclerosis.2022.06.091

Henick, B. S., Villarroel-Espindola, F., Datar, I., Sanmamed, M. F., Yu, J., Desai, S., Li, A., Aguirre-Ducler, A., Syrigos, K., Rimm, D. L., Chen, L., Herbst, R. S., & Schalper, K. A. (2022). Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer. Journal for ImmunoTherapy of Cancer, 10(7), e005025. https://doi.org/10.1136/jitc-2022-005025

Rouanne, M., Adam, J., Radulescu, C., Letourneur, D., Bredel, D., Mouraud, S., Goubet, A.-G., Leduc, M., Chen, N., Tan, T. Z., Signolle, N., Bigorgne, A., Dussiot, M., Tselikas, L., Susini, S., Danlos, F.-X., Schneider, A. K., Chabanon, R., Vacher, S., … Marabelle, A. (2022). BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer. Journal of Clinical Investigation, 132(12). https://doi.org/10.1172/jci145666

Minns, H. E., Padilla, O., Wei, H.-J., Webster-Carrion, A., Tazhibi, M., McQuillan, N., Zhang, X., Yeh, R., Zhang, Z., Szalontay, L., Pavisic, J., Garty, G., Garvin, J., Zacharoulis, S., Canoll, P., Vanpouille-Box, C. I., Menon, V., Olah, M., Rabadan, R., … Gartrell, R. D. (2022). DIPG-45. Radiation induces a robust interferon response in Diffuse Midline Glioma (DMG), improving the potential for combination immunotherapy. Neuro-Oncology, 24(Supplement_1), i28–i29. https://doi.org/10.1093/neuonc/noac079.102

Mysore, V., Tahir, S., Furuhashi, K., Arora, J., Rosetti, F., Cullere, X., Yazbeck, P., Sekulic, M., Lemieux, M. E., Raychaudhuri, S., Horwitz, B. H., & Mayadas, T. N. (2022). Monocytes transition to macrophages within the inflamed vasculature via monocyte CCR2 and endothelial TNFR2. Journal of Experimental Medicine, 219(5). https://doi.org/10.1084/jem.20210562

Galán-Díez, M., Borot, F., Ali, A. M., Zhao, J., Gil-Iturbe, E., Shan, X., Luo, N., Liu, Y., Huang, X.-P., Bisikirska, B., Labella, R., Kurland, I., Roth, B. L., Quick, M., Mukherjee, S., Rabadán, R., Carroll, M., Raza, A., & Kousteni, S. (2022). Subversion of Serotonin Receptor Signaling in Osteoblasts by Kynurenine Drives Acute Myeloid Leukemia. Cancer Discovery, 12(4), 1106–1127. https://doi.org/10.1158/2159-8290.cd-21-0692

Sahm, V., Maurer, C., Baumeister, T., Anand, A., Strangmann, J., Schmid, R. M., Wang, T. C., & Quante, M. (2022). Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker. Oncotarget, 13(1), 347–359. https://doi.org/10.18632/oncotarget.28198

Cohn, W., Melnik, M., Huang, C., Teter, B., Chandra, S., Zhu, C., McIntire, L. B., John, V., Gylys, K. H., & Bilousova, T. (2021). Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer’s Disease Brain Tissue Reveals Disease-Associated Signatures. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.766082